Mosseri Marlio Charles bought NVCT

October 24, 2025 · Form 4 insider transaction

Mosseri Marlio Charles bought 35,034 shares of Nuvectis Pharma, Inc. at $6.15 per share, a transaction worth $215.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
35,034
Price
$6.15
Total value
$215.5K
Role
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 24, 2025
Filing dateOctober 29, 2025
Shares owned after3,063,740
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.

View the original Form 4 on SEC EDGAR